Back

Complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease: 10-year outcome from the DANAMI-3–PRIMULTI trial

29 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Complex decisions in revascularisation: age, extent, and device strategy Revascularisation ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yan Zhou

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Is there an acceptable level of incomplete revascularization after PCI in elderly ACS?
Doctor B. Bahtiyar (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Perioperative colchicine increases hospital-acquired infections without reducing major cardiovascular complications in patients undergoing coronary artery bypass grafting after acute coronary syndrome
Mr L. Cartaxo Sampaio (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Drug-coated balloon strategy and major bleeding in high-bleeding-risk acute coronary syndrome
Doctor J. Yabuta (JP)
Abstract Slides Video
Presentation thumbnail
Ageism camouflaged as medical judgment – why is PCI reserved for more stable elderly ACS patients?
Doctor T. Filipovic (RS)
Abstract Slides Video
Presentation thumbnail
Less metal, same outcomes: drug-coated balloon PCI in acute coronary syndrome - real-world registry data
Doctor F. Rode (Zagreb, HR)
Abstract Slides Video

Access the full session

Session thumbnail
Complex decisions in revascularisation: age, extent, and device strategy

The Event

Event poster

ESC Congress 2026

29 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
EARTH-STEMI - Complete vs. culprit-only revascularization in older STEMI patients
1 September 2024
thumbnail
Congress Presentation
Case 1 - changing the paradigm of reperfusion therapy for STEMI patients: vision from Ukraine
31 August 2024
thumbnail
Congress Presentation
Time-dependent effects of physiology-guided staged complete revascularisation in ST-segment elevation myocardial infarction with MVD disease: a multicentre, open -labelled, randomised STAGED trial
29 August 2026
thumbnail
Congress Presentation
Clinical outcomes of complete revascularization in acute myocardial infarction patients with high bleeding risk and multivessel disease
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources